论文部分内容阅读
目的:采用沙美特罗丙酸氟替卡松吸入治疗稳定期慢性阻塞性肺疾病的临床效果分析。方法:取我院2015年1月至2016年1月收治的稳定期慢性阻塞性肺疾病患者70例,分为两组,分析两组治疗疗效。结果:实验组治疗后FEV1、FEV1/FVC水平上升程度及临床总有效率等与对照组比较有统计学的意义(P<0.05)。结论:沙美特罗丙酸氟替卡松吸入治疗稳定期慢性阻塞性肺疾病的效果显著,值得推广。
OBJECTIVE: To evaluate the clinical efficacy of salmeterol fluticasone propionate inhalation in the treatment of stable chronic obstructive pulmonary disease. Methods: Seventy patients with stable chronic obstructive pulmonary disease admitted from January 2015 to January 2016 in our hospital were divided into two groups. The curative effect of the two groups was analyzed. Results: The increase of FEV1, FEV1 / FVC and the total effective rate of the experimental group after treatment were statistically significant compared with the control group (P <0.05). Conclusion: Salmeterol fluticasone propionate inhalation is effective in treating patients with stable chronic obstructive pulmonary disease and is worth promoting.